World Journal of Gastroenterology · 2004 · 30 citations · 16 references
Decreased expression of PPARgamma may play an important role in the development of hepatocellular inflammation, necrosis and fibrosis of rats with FLD. Thus, activating PPARgamma by its ligand can be anticipated to provide a therapy target for FLD.
16
Olivier Braissant, Fabienne Foufelle, Christian Scotto et al. · Endocrinology · 1996 · 2.1K citations
Natural Fatty Acids, Experimental Pharmacology, Cellular Physiology +20
Songtao Yu, Kimihiko Matsusue, Papreddy Kashireddy et al. · Journal of Biological Chemistry · 2002 · 621 citations · Full text
Ppargamma Isoforms, Peroxisome Proliferator Activated-receptor, Fatty Liver Disease +18